Hand-foot syndrome induced by erlotinib (Tarceva(Ⓡ) ).

about

Hand-foot syndrome induced by erlotinib (Tarceva(Ⓡ) ).

Item

http://www.wikidata.org/entity/Q43438561

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Hand-foot syndrome induced by erlotinib (Tarceva(Ⓡ) ).

@en

Hand-foot syndrome induced by erlotinib

@nl

type

Item

label

Hand-foot syndrome induced by erlotinib (Tarceva(Ⓡ) ).

@en

Hand-foot syndrome induced by erlotinib

@nl

prefLabel

Hand-foot syndrome induced by erlotinib (Tarceva(Ⓡ) ).

@en

Hand-foot syndrome induced by erlotinib

@nl

P1476

Hand-foot syndrome induced by erlotinib (Tarceva(Ⓡ) )

@en

P2093

Han-Uk Kim

http://www.w3.org/2001/XMLSchema#string

Jin Park

http://www.w3.org/2001/XMLSchema#string

Ju-Ik Kim

http://www.w3.org/2001/XMLSchema#string

Kyung-Hwa Nam

http://www.w3.org/2001/XMLSchema#string

Yong-Sun Cho

http://www.w3.org/2001/XMLSchema#string

P2860

Chemotherapy-induced acral erythema

Mucocutaneous reactions to chemotherapy.

Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors.

Dermatologic side effects associated with the epidermal growth factor receptor inhibitors.

Gefitinib in combination with capecitabine as second-line therapy in patients with advanced colorectal cancer (aCRC): a phase I/II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).

[Hand-foot syndrome: A new side effect of erlotinib].

P304

e190-2

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-4632.2012.05780.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Seok-Kweon Yun

P577

2013-05-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23675736

http://www.w3.org/2001/XMLSchema#string